Biotest GmbH & Co. KGaA (HAM:BIO0)
Germany · Delayed Price · Currency is EUR 33.40
0.00 (0.00%)
At close: Nov 3, 2026
Biotest GmbH & Co. KGaA Market Cap
Biotest GmbH & Co. KGaA has a market cap or net worth of €1.32 billion as of November 4, 2026. It is the 7,875th most valuable company in the world and the 139th biggest in Germany. Its market cap has decreased by 6.18% in one year.
Market Cap
1.32B
Enterprise Value
2.06B
Revenue
648.90M
Global Rank
Country Rank
#139 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since January 14, 2025, Biotest GmbH & Co. KGaA's market cap has decreased from 1.37B to 1.32B, a decrease of -3.47%. That is a compound annual growth rate of -1.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 1.32B | -8.24% |
| Dec 30, 2025 | 1.44B | 5.20% |
| Jan 14, 2025 | 1.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novogenia AG | 78.00M |
| 2invest AG | 42.21M |
| Biomark Diagnostics | 28.32M |
| Vidac Pharma Holding | 22.61M |
| Paion AG | 363.82K |
| bioXXmed AG | 254.19K |
| co.don AG | 187.06K |
| MagForce AG | 91.72K |